Arthritis Self-Management Education Program

Arthritis Self-Management Education -- Dose Response

We will develop brief versions of the classic 6-week Arthritis Self-Management Program and evaluate their effectiveness.

Study Overview

• Status: Completed
• Conditions: Arthritis
• Intervention / Treatment: Behavioral: Arthritis Quick Start; Other: Delayed treatment intervention

Detailed Description

Many national statements have been made recently about the importance of evidence-based arthritis self-management to improvements in the public's health. The prevalence of arthritis is increasing as the US population ages; the prevalence of arthritis-related disability is higher among Blacks than Whites. Effective arthritis self-management education programs with varying formats have been developed and found effective. Despite this, many Arthritis Foundation chapters and arthritis units of state health departments have found dissemination difficult, and cite the time demands (6 weekly sessions, 2 hours/session) of the classic arthritis self-management education program (ASMP) as a major barrier. Researchers at the University of North Carolina at Chapel Hill and Stanford University will develop and evaluate two "low dose" arthritis self-management programs. The study will be conducted in three phases. Phase One (Development): Researchers will conduct needs assessments with arthritis self-management program disseminators, rheumatologists and other arthritis health professionals, and potential program users to determine preferred content, length, and schedule. Using findings from these assessments, researchers will develop two "low dose" versions of the ASMP. Phase Two (Implementation and Evaluation): Researchers will evaluate the "response" (effectiveness) of both "low dose" interventions in a randomized controlled trial (4 months) and a longitudinal study (one year). We will measure four outcomes: (1) Self-Management Behaviors, (2) Arthritis Self-Efficacy, (3) Health-related Quality of Life (Self-reported Health, Pain, Disability, Fatigue, Activity Limitation, and Health Distress); and (4) Health Care Utilization. A sample of 700 adults with diagnosed arthritis or chronic joint pain, including 200 African Americans, will participate in the study. All data will be gathered via self-administered mailed questionnaires, with telephone follow-up as needed. We will use analysis of co-variance and structural equation modeling to evaluate effectiveness. Researchers will also compare the effectiveness of each new "low dose" program with the effectiveness of existing arthritis self-management education program options. Phase Three (Dissemination): We will consult with arthritis units of state health departments and state chapters of the Arthritis Foundation on program adoption and distribution.

• Study Type: Interventional
• Enrollment (Actual): 690
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Palo Alto, California, United States, 94304
      • Stanford University Patient Education Research Center
  • North Carolina
    • Chapel Hill, North Carolina, United States, 27599
      • University of North Carolina Center for Health Promotion & Disease Prevention

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Adults, 18 years or older
• Arthritis diagnosis
• No prior participation in arthritis self-management

Study Plan

How is the study designed?

Design Details

• Allocation: Randomized
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Arthritis self-management workshop; Comparison of two-week, lay led, scripted self-management workshop emphasizing action planning, problem-solving, and content specific to arthritis.	Behavioral: Arthritis Quick Start; Two week, lay led, workshop focusing on goal setting, problem solving, and content specific to disease management.; Other: Delayed treatment intervention; After four months delay, participants in Control Group receive Experimental workshop.
Other: Delayed treatment control; After 4 month delay, participants in Control Group receive Experimental intervention.	Other: Delayed treatment intervention; After four months delay, participants in Control Group receive Experimental workshop.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Self-Efficacy	10-1-05-9-30-09

Secondary Outcome Measures

Outcome Measure	Time Frame
Self-reported health	10-1-05-9-30-09

Collaborators and Investigators

• Sponsor: University of North Carolina, Chapel Hill
• Collaborators: Stanford University; Centers for Disease Control and Prevention
• Investigators: Principal Investigator: Jean Goeppinger, PhD, BSN, University of North Carolina, Chapel Hill; Principal Investigator: Kate Lorig, DrPH, BSN, Stanford University

Study record dates

Study Major Dates

• Study Start: October 1, 2006
• Primary Completion (Actual): December 1, 2007
• Study Completion (Actual): December 1, 2008

Study Registration Dates

• First Submitted: April 25, 2007
• First Submitted That Met QC Criteria: April 26, 2007
• First Posted (Estimate): April 27, 2007

Study Record Updates

• Last Update Posted (Estimate): January 28, 2010
• Last Update Submitted That Met QC Criteria: January 27, 2010
• Last Verified: January 1, 2010

More Information

Terms related to this study

• Keywords: Community programs; Disease self-management
• Additional Relevant MeSH Terms: Joint Diseases; Musculoskeletal Diseases; Arthritis
• Other Study ID Numbers: 06-0398-1-3; S3521-24/24 (Other Grant/Funding Number: CDC)